Exemestane

🧮 Dose calculator

Breast cancer (hormonal therapy) · Regimen source: FDA Aromasin · 2.1

• • With strong CYP3A4 inducers (rifampin, phenytoin): 50 mg. FDA Aromasin · 2.2

Enter age (weight is optional for this regimen).

👥 Special populations

• 🤰 PregnancyDangerous / avoid

  Label: can cause fetal harm. Dangerous in pregnancy. FDA Aromasin · 8.1

  “Risk Summary Based on findings in animal studies and its mechanism of action , AROMASIN can cause fetal harm when administered to a pregnant woman [see Clinical Pharmacology (12.1) ] .”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Aromasin · 8.2

  “Risk Summary There is no information on the presence of exemestane in human milk, or on its effects on the breastfed infant or milk production.”

• 👶 ChildrenSafety not established

  Label: safety and effectiveness in children have not been established. FDA Aromasin · 8.4

  “Safety and effectiveness in pediatric patients have not been established.”

• 👴 Older adultsNo data

  The source for this drug has no section for this group.

• ⚥ Females & males of reproductive potentialUse with caution

  Label has advice on pregnancy testing, contraception or fertility for females and males. FDA Aromasin · 8.3

  “Contraception Females AROMASIN can cause fetal harm when administered to a pregnant woman [see Use in Specific Populations (8.1) ] .”